Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost-effectiveness analysis of the AURELIA trial
Wysham, W.Z, Schaffer, E.M, Coles, T.M, Roque, D.R, Wheeler, S.B, Kim, K.H
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article